"
Therapeutic Potential of Staphylococcal Bacteriophages for Nasal Decolonization of Staphylococcus aureus in Mice"
written by Madhavi H. Narasimhaiah, Jiya Y. Asrani, Sundaram M. Palaniswamy, Jagadeesh Bhat, Shilpa E. George, Rajamuthu Srinivasan, Aradhana Vipra, Srividya N. Desai, Raghu Patil Junjappa, Panchali Roy, Bharathi Sriram, Sriram Padmanabhan,
published by
Advances in Microbiology,
Vol.3 No.1, 2013
has been cited by the following article(s):
|
[1]
|
Clinical utilization of bacteriophages: a new perspective to combat the antimicrobial resistance in Brazil
The Brazilian Journal of Infectious Diseases,
2020
DOI:10.1016/j.bjid.2020.04.010
|
|
|
|
|
[2]
|
Phage therapy as a potential solution in the fight against AMR: obstacles and possible futures
Palgrave Communications,
2020
DOI:10.1057/s41599-020-0478-4
|
|
|
|
|
[3]
|
Community-acquired pneumonia: aetiology, antibiotic resistance and prospects of phage therapy
Journal of Chemotherapy,
2020
DOI:10.1080/1120009X.2020.1807231
|
|
|
|
|
[4]
|
Bacteriophage Procurement for Therapeutic Purposes
Frontiers in Microbiology,
2016
DOI:10.3389/fmicb.2016.01177
|
|
|
|
|
[5]
|
Bacteriophage-derived CHAP domain protein, P128, kills Staphylococcus cells by cleaving interpeptide cross-bridge of peptidoglycan
Microbiology
,
2014
DOI:10.1099/mic.0.079111-0
|
|
|
|